Timing of Angiography and Outcomes in High-Risk Patients With Non–ST-Segment–Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban)
暂无分享,去创建一个
M. Sabatine | S. Mehta | C. Bode | P. Steg | G. Ducrocq | T. Cuisset | P. Deharo | S. Wiviott | C. Pollack | Marc Cohen | Y. Elbez